The NIA-AA revised clinical criteria for Alzheimer's disease: are they too advanced?
Int Psychogeriatr
.
2023 Dec;35(12):679-681.
doi: 10.1017/S1041610223000868.
Epub 2023 Sep 27.
Authors
Angelo Bianchetti
1
,
Manubu Ikeda
2
,
Raimundo Mateos
3
,
Sara Mondini
4
,
Kiran Rabheru
5
,
Carlo Serrati
6
,
Diego De Leo
7
Affiliations
1
Department of Medicine and Rehabilitation, S. Anna Hospital, Brescia, Italy.
2
Department of Psychiatry, Osaka University, Osaka, Japan.
3
Department of Psychiatry, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain.
4
Department of Philosophy, Sociology, Education and Applied Psychology, University of Padova, Padova, Italy.
5
Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada.
6
Department of Neurology, San Martino Hospital, Genova, Italy.
7
Department of Psychology, Primorska University, Primorska, Slovenia.
PMID:
37753728
DOI:
10.1017/S1041610223000868
No abstract available
MeSH terms
Alzheimer Disease* / diagnosis
Biomarkers
Disease Progression
Humans
Substances
Biomarkers